TickerFacts.

Interpace Biosciences, Inc. (IDXG): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$5.83M
Year ended 2025-12-31
$4.46M
Trailing 12 months to 2026-06-30
$16.35M2010-12-31: $16.35M2011-12-31: $1.99M2012-12-31: -$10.29M2013-12-31: -$3.51M2014-12-31: -$16.38M2015-12-31: -$19.84M2016-12-31: -$7.61M2017-12-31: -$15.26M2018-12-31: -$8.67M2019-12-31: -$18.96M2020-12-31: -$13.98M2021-12-31: -$8.72M2022-12-31: -$7.69M2023-12-31: $3.79M2024-12-31: $4.65M2025-12-31: $5.83M$5.83M
2010-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$5.83M+25.5%2026-03-30, From 2025-01-01
2024-12-31$4.65M+22.6%2026-03-30, From 2024-01-01
2023-12-31$3.79Mn/m2025-03-31, From 2023-01-01
2022-12-31-$7.69Mn/m2024-04-01, From 2022-01-01
2021-12-31-$8.72Mn/m2023-03-27, From 2021-01-01
2020-12-31-$13.98Mn/m2022-03-31, From 2020-01-01
2019-12-31-$18.96Mn/m2021-04-01, From 2019-01-01
2018-12-31-$8.67Mn/m2021-01-19, From 2018-01-01
2017-12-31-$15.26Mn/m2019-03-21, From 2017-01-01
2016-12-31-$7.61Mn/c2018-03-23, From 2016-01-01
2015-12-31-$19.84Mn/m2017-03-31, From 2015-01-01
2014-12-31-$16.38Mn/m2016-03-30, From 2014-01-01
2013-12-31-$3.51Mn/m2015-03-05, From 2013-01-01
2012-12-31-$10.29Mn/m2014-03-06, From 2012-01-01
2011-12-31$1.99M-87.9%2013-03-15, From 2011-01-01
2010-12-31$16.35Mn/a2012-03-09, From 2010-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Interpace Biosciences, Inc. (IDXG)2025-12-31$5.83M+25.5%
Utah Medical Products Inc (UTMD)2025-12-31$14.69M-0.9%
Retractable Technologies Inc (RVP)2025-12-31-$7.06Mn/m
Cytosorbents Corp (CTSO)2025-12-31-$12.38Mn/m
ClearPoint Neuro, Inc. (CLPT)2025-12-31-$23.93Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31$462.4Kn/m
SS Innovations International, Inc. (SSII)2025-12-31-$18.54Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$3.88M+57.9%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$48.96Mn/m

Compare IDXG, UTMD, RVP, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗